These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27583690)

  • 41. The Search for a Crystal Ball to Predict Early Recovery From Peripartum Cardiomyopathy?
    Elkayam U; Habakuk O
    JACC Heart Fail; 2016 May; 4(5):389-91. PubMed ID: 27126284
    [No Abstract]   [Full Text] [Related]  

  • 42. Peripartum cardiomyopathy: a single institution 5-yr experience.
    Elsamragy S; Babazade R; Simon M; Ibrahim M; Vadhera RB
    Br J Anaesth; 2019 Oct; 123(4):e491-e493. PubMed ID: 31443917
    [No Abstract]   [Full Text] [Related]  

  • 43. Peripartum Cardiomyopathy is Missing.
    Pfeffer TJ; Berliner D; Bauersachs J
    Dtsch Arztebl Int; 2022 Jan; 119(4):57. PubMed ID: 35410671
    [No Abstract]   [Full Text] [Related]  

  • 44. It Is Time to Offer Genetic Testing to Women With Peripartum Cardiomyopathy.
    Arany Z
    Circulation; 2022 Jul; 146(1):4-5. PubMed ID: 35858163
    [No Abstract]   [Full Text] [Related]  

  • 45. Peripartum cardiomyopathy: disease or syndrome?
    Baris L; Cornette J; Johnson MR; Sliwa K; Roos-Hesselink JW
    Heart; 2019 Mar; 105(5):357-362. PubMed ID: 31693481
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Re: Subsequent reproductive outcome among women with peripartum cardiomyopathy: a nationwide study.
    Cauldwell M; Nelson-Piercy C
    BJOG; 2018 Jul; 125(8):1039-1040. PubMed ID: 29468806
    [No Abstract]   [Full Text] [Related]  

  • 47. Reply to 'Bromocriptine for the treatment of peripartum cardiomyopathy: comparison of outcome with a nationwide Danish cohort'.
    Hilfiker-Kleiner D; Sliwa K; Bauersachs J
    Eur Heart J; 2018 Oct; 39(37):3478. PubMed ID: 30016421
    [No Abstract]   [Full Text] [Related]  

  • 48. Peripartum cardiomyopathy or acute myocardial infarction: how to face the challenge?
    Sławek-Szmyt S; Grygier J; Łączak M; Ropacka-Lesiak M; Grygier M; Lesiak M
    Pol Arch Intern Med; 2023 Jan; 133(1):. PubMed ID: 36269308
    [No Abstract]   [Full Text] [Related]  

  • 49. Peripartum cardiomyopathy - challenges of diagnosis and management. Stay alert and implement BOARD treatment.
    Ciepłucha W; Ciepłucha A; Walgamage T; Subramaniapillai M; Walgamage M; Klotzka A; Katarzyńska-Szymańska A; Gwizdała A; Keller D; Lesiak M
    Kardiol Pol; 2022; 80(6):715-716. PubMed ID: 35611929
    [No Abstract]   [Full Text] [Related]  

  • 50. Peripartum cardiomyopathy - a global challenge.
    Bauersachs J; Koenig T
    Eur J Heart Fail; 2022 Sep; 24(9):1737-1738. PubMed ID: 35870186
    [No Abstract]   [Full Text] [Related]  

  • 51. Peripartum cardiomyopathy and pre-eclampsia: two tips of the same iceberg.
    Halliday BP; de Marvao A; Thilaganathan B
    Eur J Heart Fail; 2021 Dec; 23(12):2070-2072. PubMed ID: 34263509
    [No Abstract]   [Full Text] [Related]  

  • 52. Promoting Full Recovery and Improved Relapse-Free Prognosis in the Diagnosis and Treatment of Peripartum Cardiomyopathy.
    Fett JD
    J Am Coll Cardiol; 2020 Nov; 76(20):2365-2367. PubMed ID: 33183510
    [No Abstract]   [Full Text] [Related]  

  • 53. Myocardial Recovery in Peripartum Cardiomyopathy After Hyperprolactinemia Treatment on BIVAD.
    Wiedemann D; Schlöglhofer T; Riebandt J; Neuner M; Tschernko E; Schima H; Zimpfer D
    ASAIO J; 2017; 63(1):109-111. PubMed ID: 27748657
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Peripartum cardiomyopathy: a review.
    Bhattacharyya A; Basra SS; Sen P; Kar B
    Tex Heart Inst J; 2012; 39(1):8-16. PubMed ID: 22412221
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Authors' reply re: Subsequent reproductive outcome among women with peripartum cardiomyopathy: a nationwide study.
    Guldbrandt Hauge M; Johansen M; Vejlstrup N; Gustafsson F; Damm P; Ersbøll AS
    BJOG; 2018 Jul; 125(8):1040-1041. PubMed ID: 29479809
    [No Abstract]   [Full Text] [Related]  

  • 56. The Thyroid Axis in Peripartum Cardiomyopathy: A Potential Contributor to a Multifaceted Disease.
    Tremblay-Gravel M; Pacheco C
    Can J Cardiol; 2019 Jun; 35(6):710-711. PubMed ID: 31151705
    [No Abstract]   [Full Text] [Related]  

  • 57. Peripartum Cardiomyopathy: An Important Cause of Maternal Morbidity and Mortality!
    Erhabor GE
    West Afr J Med; 2023 Jan; 40(1):1. PubMed ID: 36716124
    [No Abstract]   [Full Text] [Related]  

  • 58. Vasoinhibin Serum Levels Are Required to Demonstrate Their Role in Peripartum Cardiomyopathy Etiopathology.
    Triebel J; Clapp C; Martínez de la Escalera G; Bertsch T
    ASAIO J; 2017; 63(4):e50. PubMed ID: 28657930
    [No Abstract]   [Full Text] [Related]  

  • 59. Peripartum cardiomyopathy prognostication using cardiac magnetic resonance imaging.
    Feghaly J; Ampadu J; Mooradian A; Salem EA
    Br J Hosp Med (Lond); 2020 Mar; 81(3):1-2. PubMed ID: 32240001
    [No Abstract]   [Full Text] [Related]  

  • 60. Poor Outcomes in Poor Patients?: Peripartum Cardiomyopathy-Not Just Black and White.
    Bauersachs J
    JAMA Cardiol; 2017 Nov; 2(11):1261-1262. PubMed ID: 29049487
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.